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Abstract: The integration of genetic and environmental factors that regulate the gene expression
patterns associated with exercise adaptation is mediated by epigenetic mechanisms. The organisation
of the human genome within three-dimensional space, known as chromosome conformation, has
recently been shown as a dynamic epigenetic regulator of gene expression, facilitating the interaction
of distal genomic regions due to tight and regulated packaging of chromosomes in the cell nucleus.
Technological advances in the study of chromosome conformation mean a new class of biomarker—the
chromosome conformation signature (CCS)—can identify chromosomal interactions across several
genomic loci as a collective marker of an epigenomic state. Investigative use of CCSs in biological
and medical research shows promise in identifying the likelihood that a disease state is present or
absent, as well as an ability to prospectively stratify individuals according to their likely response to
medical intervention. The association of CCSs with gene expression patterns suggests that there are
likely to be CCSs that respond, or regulate the response, to exercise and related stimuli. The present
review provides a contextual background to CCS research and a theoretical framework discussing the
potential uses of this novel epigenomic biomarker within sport and exercise science and medicine.
Keywords: genetics; epigenetics; exercise; exercise training; chromatin; sports medicine
1. Introduction
Discovering and quantifying the physiological response to external stimuli is a cornerstone of
sport and exercise science [1]. Specifically, exercise scientists are interested in the transitory response to
exercise and the process by which this translates to long-term adaptation. In recent decades, exercise
physiologists have shifted focus toward understanding how changes in whole-body phenotypes are
underpinned by adaptations at the cellular and subcellular levels [2]. In the 1970s and 1980s, the
introduction of biochemical techniques in sport and exercise science enriched the understanding of
cellular function during and after exercise, preceding the recent shift toward molecular techniques
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and the emergence of molecular exercise physiology [3]. A combination of advancing technology and
lower cost now allow the study of whole-body, cellular and molecular responses to physical activity
simultaneously. Thus, molecular exercise physiology is credited with complementing and improving
‘classical’ exercise physiology approaches [4] and is likely to accelerate further development in the
field of sport and exercise science.
Human phenotypes (traits) are determined by the selective utilisation of an individual’s unique
genotype (DNA sequence) upon exposure to environmental stimuli, such as exercise [5]. When exercise
stimuli are experimentally controlled, considerable variation exists in the way that individuals respond,
suggesting that there is a significant influence of genetic factors [6]. Consequently, sport and exercise
genomics has emerged as a sub-discipline of molecular exercise physiology, and aims to understand
the organisation and function of the genome in athletic settings [7]. Sports genomics typically explores
whether common DNA sequence variants, such as single nucleotide polymorphisms (SNPs) [5], are
associated with a phenotype of interest. Indeed, genomic differences exist between individuals that
may explain the variance in skeletal muscle fibre type [8], aerobic capacity [6] and muscle strength [9],
and there are several specific genotypes associated with the achievement of elite athlete status [7,10].
Genetic approaches such as linkage analysis, candidate gene studies, genome-wide associated studies
(GWAS) and whole exome or genome sequencing, while able to test the relationship between fixed
genetic variability and quantifiable traits [11], are less able to also account for and understand the
role of the environment. Another level of biological regulation, known as epigenetics, is recognised
as being essential to the control and programming of gene expression [12]. While heritable genetic
factors contribute to approximately 50–60% of exercise-related traits [6,8,13–15], with the environment
contributing the remainder, epigenetic mechanisms describe the integration of the two and enable the
control of gene activity without changes in DNA sequence [12,16–18]. As such, the epigenetic regulation
of genes in response to external stimuli is an important modulator of physiological adaptation, and
epigenetic research is gaining interest in sport and exercise to understand how cells, tissues and organs
are able to adapt to exercise, training and related physiological challenges [19].
Growing interest in fundamental genetic and epigenetic mechanisms has driven new directions
in sport and exercise science, with technological advances in molecular biology allowing researchers
to embrace new techniques and generate new hypotheses in a more applied way. Chromosome
conformation is an epigenetic modification that has gained interest in biological and medical research
following evidence that some three-dimensional arrangements within the human genome are dynamic
in response to external stimuli [20], whilst other conformations can modulate responses to external
stimuli without structural rearrangement [21]. However, nothing is known about whether changes in
chromosome conformation occur in response to exercise and related stimuli. The aims of this review
are to summarise the importance and translation of the human genome to sport and exercise science,
and to discuss the potential of a recently developed measure—the chromosome conformation signature
(CCS)—to explore the dynamic nature of epigenetics in sport and exercise science.
2. Importance of the Genome to Human Biology
The human genome is the complete set of nucleic acid sequences, encoded as deoxyribonucleic
acid (DNA), which are around 99.9% identical between individuals [22]. Comprised of around 3 billion
base pairs (bp), only around 1–2% of the genome contains sequences for protein-coding genes. These
genes contain sequences transcribed to ribonucleic acid (RNA), which is translated to form proteins,
which make up the structure of organs and tissues, control chemical reactions, and transport signals
between cells [23]. Accordingly, the information stored as DNA is the essential foundation for the
development and function of the human body [24].
The remaining 98–99% of non-coding DNA was once considered “junk”, as it had no known
functions. However, it is now appreciated that much of this non-coding DNA is crucial to the
functioning of cells, especially maintaining the stability of the genome and regulating the activity of
genes. Much of this non-coding DNA is transcribed into non-coding RNA with various regulatory
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activities, whilst there are also DNA sequences that act as regulatory elements, determining when
and where genes are turned on and off. Depending on their functions and locations, these include
promoters, enhancers, silencers and insulators [25]. Tight regulation and plasticity in the expression of
specific genes during and/or following exercise is central to adaptation [26], with the mechanisms that
govern the regulation and function of the human genome having particular relevance to sport and
exercise science and medicine.
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 Figure 1. Nucleosomes and chromatin. (i) Nucleosome: Functional wrapping of 146 bp DNA
strand around histone octamer (eight histone proteins). (ii) Ten nanometre nucleosome fibre:
Repeating arrangement of individual nucleosomes linked together by continuous “linker” DNA
sections approximately 20 bp long. (iii) Thirty nanometre chromatin fibre: Repeated folding of 10 nm
fibre. (iv) Three hundred nanometre chromatin fibre: Repeated looping of 30 nm fibre to form loops
averaging 300 nm in length. The 300 nm fibres are further compressed to produce a 700 nm × 250 nm
fibre before being tightly coiled to produce the chromatid of a chromosome.
Genomic DNA is packaged by tightly wrapping around histone proteins in a complex known
as chromatin [27] to allow the almost 2 m of linear DNA in each human cell to fit into the nucleus.
Chromatin has a repeating and functional subunit known as a nucleosome, consisting of eight histone
proteins and approximately 146 DNA bp, and regulates the access of transcriptional machinery to DNA
that must unravel before transcription [28] (Figure 1). This unravelling, known as chromatin remodeling,
is an epigenetic process regulated by cell-specific histone modifications, such as methylation, acetylation
and phosphorylation, that mark genes, transcription start sites and stretches of regulatory DNA to
control gene expression [27]. Near the start of a gene is the core promoter, serving as a docking site
for RNA polymerase II and transcription factors to form the transcription pre-initiation complex.
Approximately 250 bp upstream lies the proximal promoter, which is a sequence containing primary
regulatory elements where general transcription factors bind. Enhancer regions are often located
hundreds or thousands of bp away from transcription start sites, and are short stretches of DNA that
can increase the transcription of genes [25]. As these regulatory elements of the DNA sequence are
not adjacent to one another, loops in the DNA bring distal enhancer regions closer to the proximal
promoter. Functional organisation of the genome is, therefore, not simply linear along chromosomes,
as DNA elements can regulate genes located far away on the same (intrachromosomal) or different
(interchromosomal) chromosomes, due to the organisation of the genome in three-dimensional nuclear
space [29,30] (Figure 2). Importantly, the capacity for distal chromosomal regions to enter close physical
proximity and facilitate interaction of DNA elements makes spatial chromatin organisation a key
mechanism in regulating gene expression [17,31,32]. Critically, genome packaging and rearrangement
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is non-random, with spatial chromatin organisation assuming a key functional role in the retrieval
and translation of genetic instructions [33]. While the analysis of spatial chromatin organisation has
the potential to provide valuable insight into the role of genome packaging on gene expression in
various settings, how this affects the expression of genes involved in the response to exercise and
related stimuli is unknown.
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Figure 2. Functional genome organisation. Hypothetical example of three chromosomal arrangements
from top to bottom. (a) Linear arrangement of an example gene, with non-adjacent enhancer and
promoter regions separated by 100 s/1000 s of bp. (b) Intrachromosomal interaction. Looping of genomic
sequence as a consequence of three-dimensional chromatin arrangement, bringing distal enhancer
and promoter regions on the same chromosome into close physical proximity. (c) Interchromosomal
interaction. Tight packaging of chromosomes within the nuclear space brings promoter and enhancer
regions of different chromosomes into close physical proximity.
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3. Assessment of Chromosome Conformation
Determining how chromosomes are positioned and organized within the nucleus, and how this
positioning changes with respect to environmental stimuli, is critical to understanding the clinical
relevance of chromatin architecture. Over the years, several methods which vary in their level of
molecular insight, resolution, and technical complexity have been developed to study chromosome
architecture, with the most well-developed techniques based on chromosome conformation capture
(3C) [29,34]. The seminal report on the use of 3C was described in 2002, where researchers used a
yeast model system to develop a methodology to detect the frequency of interaction between any
two genomic loci [35]. The basis of 3C is to identify and quantify the number of interactions between
genomic loci, potentially separated by many thousands of nucleotides in the linear genome, within
three-dimensional space [36]. In laypersons’ terms, the 3C methodology “freezes” the 3D genome
in time and asks “which genomic regions are interacting with each other?” Operationally, the basic
3C method involves fixation of cells/nuclei with the chemical agent formaldehyde to cross-link DNA
and protein interactions, which stabilizes interactions between genomic loci. Next, the genome
is fragmented using restriction enzymes, which cleaves DNA into fragments at or near specific
recognition sites in the genome. Following genomic fragmentation, a proximity-based ligation reaction
step under conditions that favour re-ligation between cross-linked interacting fragments that were
physically proximal during fixation over re-ligation between fragments that are not cross-linked
(genomic regions that were physically distant during fixation). This results in a stable 3C ‘library’
of interactions which can be detected and quantified using several different approaches, primarily
PCR-based methods and next generation sequencing. This composition of this 3C library can vary
depending on the restriction enzymes used and yields a way to identify and quantify chromosomal
interactions as a starting point. In addition, the PCR methods used to detect interactions from a
3C library requires prior knowledge of the targets of interest. Since the initial description of the
3C approach, several methodological variants have been developed to study genome architecture,
including circular chromosome conformation capture (4C), chromosome conformation capture carbon
copy (5C), combined chromosome conformation capture ChIP cloning (6C), ChIA-PET, Hi-C, and
RNA-TRAP that are well summarised elsewhere [29,30,37,38]. Each technique varies by cost, resolution,
bandwidth and throughput, and can be used in combination to provide a view of the genome in vivo
for research use, though not a clinical quality assay [29]. The resulting view of spatial chromatin
organisation is used to determine the expression state of genes regulated by physical contacts in the
nuclear space.
Chromosome conformation signatures (CCSs) are collections of multiple DNA contacts associated
with specific functional outcomes such as disease states and gene expression patterns [29], and
technologies for identifying such signatures have also been developed. Recently, an approach with
a focus on clinical and industrial scale screening and applications was developed [39–42]. Like the
original 3C methodology, EpiSwitch™ detects the absence or presence of interactions between two
sites in the genome. However, a key difference in the approach is that unlike traditional 3C, EpiSwitch
leverages in silico knowledge of interaction sites within the genome to guide the interactions that
are evaluated. In essence, the approach asks “which of the key regulatory interactions exist?” in a
given sample. Another difference between EpiSwitch and conventional 3C analysis is scale. While only
single interaction pairs at a time are identified by PCR in 3C, initial EpiSwitch screening is done via a
comparative genomic hybridization (CGH) array, with the ability to assess the absence or presence of
over 1 million regulatory interaction pairs at a time. This initial array-based screening step can then be
followed by PCR or sequencing-based detection for interactions of interest.
At present, CCSs are not commonly applied in sport and exercise science and medicine, but may
offer a viable method to identify the epigenomic factors underpinning responses and adaptations to
exercise and related stimuli. Though the terms chromosome and chromatin are used interchangeably
in the related literature, in this review we will refer to chromosome conformation signatures.
Genes 2020, 11, 905 6 of 19
4. Chromosome Conformation Signatures (CCSs)
Chromosome conformation signatures represent a novel epigenetic biomarker of structural
epigenetic changes in genomic architecture, documenting collections of DNA contacts associated
with specific physiological outcomes [29]. With multiple genomic loci contributing to phenotypic
differences [43], a signature of multiple DNA contacts is likely to provide greater biological insight than
a single contact alone. An analogy would be how singular factors underpinning running performance
(VO2max, lactate threshold, running economy, VO2 kinetics) provide better informative value when
analysed in combination [44]. Similarly, the polygenic influence on physical performance [45]
lead scientists in the field of sports genomics to consider the combined influence of multiple
genetic variants [46] as opposed to single genomic loci. That the expression of numerous genes
is increased/decreased according to function and drives physiological adaptation [26] leads us to
hypothesise that there are detectable conditional CCSs associated with acute and chronic responses to
exercise and related stimuli. Specifically, the dynamic nature of chromatin organisation [20] suggests
there may be signatures associated with both transient responses and more persistent phenotypic
changes, reflecting the underlying epigenetic regulatory landscape. Recent evidence that transcription
factor activity, in particular, is affected by promoter region interactions [21,47] demonstrates the
permissiveness of CCSs to facilitate acute and persistent physiological alterations. Recent application
of CCSs [39,40] has shown that this biomarker modality can be applied to whole blood samples [41] to
provide stable, binary readouts between two states (pre-intervention vs. post-intervention, disease vs.
non-diseased) based on the presence or absence of a signature [29,39,42]. It is important to note that
study of CCSs requires consideration of participants individually, as opposed to their contribution
to a collective group mean. Mean values are routinely calculated and reported in sport and exercise
research to summarise group data, providing a measure of central tendency [48]. However, extreme
values influence group means, particularly in small samples, and are less suited to investigating
variability between individuals. The binary nature of CCS readouts offers a different approach, with
samples (participants) grouped according to the presence or absence of a specific signature, as opposed
to each sample contributing a numerical value on a scale, such as when measuring VO2max or jump
height. Hence, CCS technologies identify the flexibility or inflexibility of epigenomic states, rather
than reporting the magnitude of gene expression, across multiple genomic loci. Importantly, the way
in which CCSs reorganise in response to stimuli to regulate gene expression appears to be one of
the earliest detectable events, preceding other epigenetic modifications, transcription factor binding
and transcription [49]. Due to the fact that DNA is spatially organized into 3D structures, and distal
genomic regions can be brought into proximity through chromatin folding, it would be expected that
such DNA sequences may also exhibit coordinated epigenetic marks, such as histone modifications
and DNA methylation. Indeed, a recent study using a variation of CCS, termed Methyl-HiC, revealed
coordinated DNA methylation status between distal genomic segments that are in spatial proximity in
the nucleus [49]. Such combined approaches would be important to understand how epigenetic marks
are dynamically regulated with characteristic patterns in different tissues. The ability to detect these
early molecular changes may provide considerable benefit to sport and exercise scientists who seek to
understand the initial drivers of adaptation.
5. Studies Using CCSs in Biomedical Research
The potential of CCS has emerged in the last decade, with a number of human studies in medicine
demonstrating promising results [39–42,50]. An intriguing advantage is that CCSs can indicate the
likelihood that a specific condition or disease is present [39,40], or can be used to identify individuals
who are likely to be responsive or non-responsive to medical intervention [41]. Importantly, the
diagnostic concepts of sensitivity and specificity are common to each approach, describing the ability
of a test to identify those with or without a given disease or trait [42,51]. Although sport and exercise
scientists do not typically investigate disease or therapeutic intervention, medical research provides
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valuable insight into the potential use of CCS in exercise-related settings as part of a move towards
more targeted approaches and personalised interventions.
One of the first studies to assess the ability of a collective ‘signature’ of contacts (markers) to
detect the presence or absence of a disease was in oncology. After identifying loops associated with
specific candidate genes, researchers explored whether a CCS could distinguish between patients with
melanoma and non-melanoma skin cancers [40]. Eighty-six genomic loci were identified as potential
regions of chromatin investigation and screened for chromatin loops in blood samples from melanoma
patients. From this screen, a panel of the 15 most informative and robust melanoma markers was
identified. The panel successfully discriminated between melanoma and non-melanoma samples with
81.4% sensitivity and 76.5% specificity, and could successfully identify non-melanoma blood samples
from healthy controls with 87% accuracy. Consequently, the binary state of chromosome conformations
was proposed as a quick, non-invasive test for melanoma, potentially informing treatment, as well as
detecting pre-symptomatic molecular changes that could improve diagnosis and prognosis [40]. More
recently, Salter and colleagues identified a blood-based CCS that discriminated between amyotrophic
lateral sclerosis (ALS; a form of motor neurone disease) patients and healthy controls [39]. In a multi-step
selection process, a microarray-based screen on 13,880 potential conformations across 308 genomic
loci specific to the immune-footprint of ALS was used to select the chromosomal interactions that
best discriminated ALS from healthy controls. From this initial pool, 153 interactions were translated
to polymerase chain reaction (PCR)-based detection and evaluated over multiple rounds of marker
selection/reduction on increasing numbers of patient samples, until the top eight interactions were
identified and used to create a CCS. The CCS discriminated patients from controls with 83.3% sensitivity
and 76.9% specificity and provided proof-of-concept that changes in genomic architecture in blood
samples could reliably detect physiological changes associated with a disease. Ongoing investigation
into the role of CCSs in ALS is currently being studied in a clinical trial setting (ClinicalTrials.gov,
NCT04259255). These studies demonstrate the capacity to determine presence or absence of a specific
disease by CCS, which is particularly important given that chromosomal conformation is the smallest
unit of genome regulation linked to phenotype [29,43] and that conformational changes are amongst
the earliest detectable events [29,49]. The latter is especially pertinent in conditions like ALS, where
early symptoms are subtle and may lead to delayed diagnosis [39].
Identifying individuals who are more/less likely to respond to a treatment intervention represents
another attractive use of CCSs, where predicting the response to treatment can be highly challenging.
A hypothetical example of a process to enable patient selection for drug response is depicted in Figure 3.
Recently, Carini and colleagues described a CCS of inadequate response to methotrexate (MTX), a drug
used to treat rheumatoid arthritis (RA) [41], in early RA patients. Blood samples taken from early RA
patients prior to treatment were used to screen 13,222 chromosomal interactions across 123 genetic
loci previously associated with RA to identify a ‘non-response’ signature. Taking a similar stepwise
approach with logistical regression to refine the CCS, a CCS consisting of five markers was identified
and correctly classified 90% of existing patients as responders or non-responders to MTX, with 86%
specificity in a blinded test cohort. As drug responsiveness is a significant predictor of long-term
outcome in RA [52], this study demonstrated the value of using a CCS-based biomarker approach to
identify patients’ likelihood of response to medical intervention.
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6. Features of CCSs Applicable to Sport and Exercise Science and Medicine
Biomarkers are characteristic biological properties that can be detected in blood or tissue to
indicate a physiological or pathological process [53]. Biomarker analysis is routine in modern sport
and exercise medicine research, with many institutions investigating cells, molecules, genes, enzymes
and hormones via multiple techniques. The potential to include novel data concerning the earliest
detectable events, within the smallest detectable unit of regulated genome [29], make CCSs an attractive
tool to complement existing k owledge o th m chanis s governin g nome r gulation in response
to exerci e a d relat d timuli.
A notable adv ntage of CCSs is the link betw en epigenetic regulation and phenotype [39]. Whilst
GWAS studies highlight genomic loci associated with phenotypes, causality is largely unexplained,
and epigenetic variation is not quantified [54]. Epigenome-wide association studies (EWAS) are the
epigenomic equivalent and study the proportion of phenotypic variance attributed to epigenomic
variation. However, interindividual differences identified by EWAS such as DNA methylation could
be either the cause or consequence of a phenotype [54]. While CCSs also have the potential to be the
cause or consequence of a phenotype, they integrate both genomic and epigenomic regulation of gene
expressi n at the mallest detectable l vel [43], allowing th identification of genomic loci associated
with, and therefore indicati e of, specific physiological stat s.
Notably, a CCS provides r sults on a binary basis based on the presence/absence of a specific
three-dimensional architecture for a given phenotype, as opposed to quantifying the magnitude of
difference between individuals or groups, allowing efficient stratification of samples (Figure 3). Though
CCS does not measure gene expression levels that may provide detail of subtle differences between
levels of stimuli (e.g., duration and/or intensity of exercise), investigating CCS and gene expression
simultaneously can circumvent this limitation to provide greater insight than each alone. Binary
outputs are common amongst studies of genetic variants, such as SNPs—the result is binary, according
to the presence or absence of the allele. This, however, only applies when investigating a single SNP,
which has limited value due to the highly polygenic nature of physiological traits [45]. Furthermore,
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SNPs are stable, heritable genomic features that may be more or less influential depending on other
inherited DNA sequence variations and gene-environment interactions, whereas CCSs can dynamically
reorganise in response to major external stimuli to regulate gene expression across several genomic loci.
The contribution of several genomic loci to each CCS offers superior investigative value than single
variants or conformations, with each conformation identified and refined through rigorous statistical
selection, suggesting that sport and exercise science research participants could be stratified effectively
by CCS in a number of contexts.
Within sport and exercise science, where efforts are made to predict the magnitude of training
response [55,56] or the likelihood of injury [57] using genetic association data, results are mixed, which
may be due to heterogeneity in genetic background, among other confounding factors. However, the
iterative discovery and refinement stages employed when using CCSs offers a more rigorous approach,
with the predictive ability and signature validation maintained in independent cohorts reflecting
this [39–41]. Furthermore, sample sizes in existing CCS research are relatively modest in comparison
to typical genetic studies, where larger sample sizes are recommended to achieve sufficient statistical
power [58]. In CCS research, initial screening for significant markers is performed using small subsets
of samples, with larger sample cohorts used in subsequent screening stages to achieve the statistical
power needed to approximate real-world populations [39]. Modest sample sizes, predictive accuracy
and the inclusion of multiple genomic loci make the use of CCSs in exercise-related research attractive.
An important aspect of a useful biomarker is clinical accessibility. The source of the measurement
must be easy to obtain non-invasively and provide a useful and biologically meaningful readout. For
these reasons, peripheral blood is a common biomarker source in sport and exercise science. Peripheral
blood has been used as the primary biofluid source of existing studies on CCS in clinical applications,
with the added benefit of providing a systemic readout of physiological changes. CCS readouts also
require minimal material, with as little as 50 µL of whole blood [41] routinely used. This makes sample
collection itself relatively straightforward, and highly applicable to exercise-related studies where blood
samples are collected to study a range of analytes. Relatively few studies have systematically assessed
the concordance of changes in genomic architecture between primary tissue and peripheral blood.
However, initial studies indicated that shared epigenetic characteristics, including chromatin structures,
between the primary tissue and surrogate blood-based readouts exist [40,59,60]. Nevertheless, it is
important to consider that changes in blood cell homeostasis should also be considered or controlled for,
especially in acute studies. While the exact molecular underpinnings of shared chromatin structures
are being actively researched, horizontal RNA transfer—an exosome-mediated resetting of selected
targeted cell populations—is proposed as one [61]. Exosome-based transfer of non-coding RNA and
metabolic signalling is involved in the epigenetic resetting of secondary cellular targets in distal tissues
and in peripheral blood and, crucially, is directly associated with the resetting of specific chromosome
conformations in individual effector cells [39]. Appropriate study design is, therefore, imperative to
have confidence that any observed changes detected by a CCS (such as pre- and post-intervention) can
be attributed to a defined stimulus. Lastly, while the current cost of CCS detection technologies may
limit initial uptake to institutions/organisations able to access/direct substantial funding towards such
work, technological advances and efficiency gains in scale made by specialist laboratories that perform
CCS analysis should reduce costs in time.
7. Potential Use of CCSs in Sport and Exercise Science and Medicine
Existing studies have suggested that CCSs are a valid and reliable method to identify epigenomic
state and changes associated with specific physiological stimuli. Thus, pre-existing CCSs may influence
the nature and extent of acute responses to exercise and/or chronic adaptations to training. Additionally,
rearrangement of three-dimensional chromatin structure to regulate gene expression under external
perturbations [62] suggests that alterations in CCSs may occur in response to acute exercise or chronic
training. Indeed, the chemical, electrical and mechanical signals generated by exercise are converted
to molecular events that promote physiological responses, culminating in the activation and/or
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repression of various signalling pathways regulating gene expression [63]. Furthermore, a growing
body of research in human and animal models suggests that epigenetic modifications, including DNA
methylation, histone modifications and microRNAs, are bi-directionally associated with responses to
aerobic and resistance exercise in numerous tissues including the brain, blood, skeletal muscle, adipose
tissue and epithelial buccal cells [64]. However, the regulation of gene expression and epigenetic
marks by chromosome conformations in response to exercise remains unknown, presenting a number
of scenarios where the exploration of CCSs may be of interest to sport and exercise researchers and,
subsequently, practitioners.
7.1. CCSs of Response to Single Exercise Bouts
Changes in gene expression occur after single bouts of exercise [65]. When reinforced by repeated
exercise stimuli, lasting and cumulative effects on gene expression at the protein level form the basis
of phenotypic adaptations that contribute to improved performance [26]. Elevated mRNA [66] and
hypomethylation of genes [67] are reported after a single bout of exercise, whilst expression of other
genes can be downregulated by exercise [26]. Nevertheless, the acute effect of exercise on chromatin
conformation is currently unknown, and the analysis of CCSs may provide valuable insight regarding
the regulation of multiple genomic loci in response to exercise.
A protocol involving pre- and post-exercise blood samples, plus a series of follow-up blood
samples (for example at 24, 48 and 96 h post exercise) would allow the exploration of CCSs in response
to a single exercise bout. The influence of training status [68] and macronutrient availability [69] on
mRNA responses to acute exercise should be appropriately controlled, with a non-exercise control
group also necessary. The aim of singular-bout studies would be to identify a CCS to distinguish
between pre- and post-exercise epigenomic states, which would provide insight into the temporary
rearrangement and reorganisation of chromatin conformations following exercise. Identifying such
loci would help sport and exercise researchers to understand the earliest stages of physiological
adaptation, as well as aiding the development of new targets for gene expression analyses. In such
instances, identification of key loci could be combined with mRNA profile analysis to provide a more
detailed mechanistic explanation of the adaptive response to training, with genomic interaction data
lacking an indication of gene expression magnitude or splice isoform behaviour. To explore how
CCSs respond to single bouts, separate endurance and resistance studies are recommended due to the
different molecular programmes elicited by each modality [70]. However, the inability to extrapolate
observations from single bouts to the phenotypic adaptations to long-term training is a limitation.
Consequently, training intervention studies are required to determine how CCSs respond to repeated
exercise stimuli and regulate training adaptation.
7.2. CCSs and Exercise Training
7.2.1. Adaptations of CCSs to Training
Adaptations of CCSs in response to sustained training may differ from their response to acute
exercise. Training studies will, therefore, help to ascertain whether CCSs are associated with changes
in exercise-related phenotypes that occur following persistent stimuli, and how CCSs relate to altered
gene expression profiles and epigenetic modifications that underpin these changes [71,72]. Exploring
whether phenotypic adaptations are associated with the rearrangement of CCSs during training
adaptation requires pre- and post-training blood samples, and sequential sampling throughout training
could establish the time course of CCS changes during an intervention. Specific criteria to define a
training adaptation phenotype may involve a minimum percentage change relative to pre-training. Pre-
and post-intervention blood samples from participants exhibiting the training adaptation phenotype
can be screened for chromosomal interactions that distinguish between them to identify a CCS. After
statistical refinement to detect the most discriminatory interactions, accuracy of the CCS can be tested
by randomising pre- and post-training samples into groups and observing the ability of the CCS to
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correctly discriminate between them. Validation of the signature can be achieved using an independent,
blinded cohort of participants and assessing how well a CCS determines whether samples were from
trained or untrained participants. Discovering whether specific CCSs adapt to training (or detraining)
and are associated with phenotypic changes has the potential to improve current understanding of the
mechanisms that underpin physiological adaptation.
7.2.2. Using CCSs to Predict Training Adaptations
Training studies typically quantify the magnitude of adaptations by groups. However, group data
can conceal the variability in the way individuals adapt [73], meaning individual data are important
when investigating variable training adaptations. To determine whether individual adaptations to
training (or detraining) are regulated by CCSs that are present prior to an intervention, variable
individual adaptations must be categorised.
The optimal suggested study design for quantifying individual differences in adaptation is a
replicate crossover design (control and exercise conditions administered to participants at least twice
in randomised order) [74], enabling differentiation between true individual differences and those
attributable to measurement error. Replicate crossover studies are rare in sport and exercise [75],
undoubtedly due to the challenges of conducting such trials. However, a potential alternative is for
participants to repeat a training intervention after a washout period, allowing the determination of
true individual differences in adaptation that are difficult to quantify using a single intervention [75]
(Figure 4a). These comments regarding study design also apply to the later sections of this manuscript
regarding nutritional and other interventions, but will not be mentioned there to avoid repetition.
After the interventions, participants can be ranked according to the magnitude of improvement from
pre-intervention from the largest to smallest change, allowing subsequent exploration of whether
CCSs are involved in regulating the observed adaptation. Participants ranked in the top and bottom
25% could be classified as ‘high’ and ‘low’ adapters, respectively, with pre-intervention samples from
each group compared in a ‘discovery’ phase [41] to identify chromosomal interactions associated with
high and low adapter phenotypes. The discovered CCS is refined cyclically by increasing the number
of pre-training samples from high and low adapters to define the best discriminatory interactions.
Next, randomised pre-training samples would allow the testing of the CCS’s sensitivity and specificity
to distinguish between high and low adapters, with the signature’s predictive ability validated by
prospectively stratifying the pre-training samples of independent participants and observing how
individuals adapt to training (Figure 4b).
Once experimentally validated, the use of CCS to make predictions about individualized training
adaptations could complement other efforts to identify talent and individualise training programmes.
Further directions include investigating whether CCSs regulate (and can predict) general ‘trainability’
regardless of exercise type, or if specific CCSs are associated with whether individuals who adapt
well to endurance exercise are less responsive to resistance exercise, and vice versa. The heritable
nature of exercise trainability [6,76] and muscle fibre composition [8] suggests that some individuals
are inherently suited to specific exercise types and will adapt favourably to those modalities or to
individually prescribed training dosages. To our knowledge, there is one unpublished study that
seeks to apply CCSs to this issue of exercise trainability, but no published research on the topic.
Recent investigations have observed differential expression of microRNAs in high and low adapters to
training [77,78]. Although detailed mechanistic studies on the interplay between mircroRNAs and
chromosome conformation are limited, assessing changes in local chromatin organization around loci
encoding microRNAs and the corresponding changes in microRNA expression could serve as an initial
path for exploring this relationship.
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7.3. CCSs and Nutrition
7.3.1. Responses of CCS to Nutritional Stimuli
In addition to exercise itself, o her exercise-related stimuli may be associated with CCSs. In sport
and exercise, training interventions can be supported by nutritional strategies designed to promote
adaptation, augment recovery and/or improve body composition [79]. Nutrition is an external stimulus
prompting epigenetic modifications, in isolation and co bined with exercise [80], leading us to
suggest that CCSs may r spond to dietary interventi n and/or nutrit onal supplementation to re ulate
post-exercise ne expres ion. For example, the post- xercise increase n interleukin-6 (IL-6) gene
expression is augmented under conditions of low muscle glycogen [81] and blunted by intra-exercise
carbohydrate ingestion [82]. If CCSs rearrange in response to exercise stimuli to regulate gene expression,
it is plausible that nutrition-induced changes in post-exercise gene expression are also associated with
CCS responses. Investigating this hypothesis requires a single bout and/or intervention study with
a second exercise condition, where a nutritional stimulus is imposed using dietary manipulation or
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supplementation. With stringent control of dietary intake and energy expenditure, such studies might
offer insight into how CCSs respond to exercise-related nutritional stimuli.
7.3.2. Using CCSs to Predict Responses or Adaptations to Nutritional Interventions
It is possible that pre-existing CCSs, as part of the established epigenetic landscape, are also
involved in regulating responses and adaptations to nutritional interventions. Similar to the process of
determining whether CCSs can prospectively regulate and predict adaptations to exercise training,
observing individual responses to acute nutritional stimuli or adaptations to sustained nutritional
interventions could predict how independent participants will respond under the same conditions.
A similar example (not using CCSs) is how multiple factors such as blood parameters, dietary habits
and physical activity were combined to predict glycaemic responses [83], while recent evidence in
animal models suggests that chromatin interactions are, in turn, responsive to dietary stimuli [21].
To investigate the potential use of CCSs in similar settings, pre-intervention samples from participants
exhibiting variable responses and adaptations to acute or chronic dietary changes could be screened
to determine any associations with pre-intervention CCS. The ability of that CCS to predict how an
independent population reacts to the same stimuli could then be evaluated.
7.4. CCSs and Environmental Extremes
Gene expression is affected by hot and cold climates [84–86] and conditions of low oxygen
availability [87,88], though to our knowledge, the effects of such stimuli on CCSs are unknown.
Heat acclimation is partially mediated by altered gene expression as an adaptation to peripheral
haemodynamic load [89], and could be one example of an adaptation potentially associated with the
reorganisation of specific CCSs. Initially, non-exercise studies are required to discover whether CCSs are
regulated as part of such adaptations and, depending on their outcomes, may prompt further studies
of whether CCSs are associated with the capacity to exercise in, and adapt to, extreme environments.
If variable adaptations to the same environmental stimuli are observed between individuals, further
analysis of pre-adaptation samples could determine if CCSs regulate and can predict the way an
individual will respond to a particular environmental stimulus. Such information may be valuable
to those training for sporting events held in extreme climates, or those with physically demanding
occupations periodically based in extreme climates.
7.5. Use of CCSs to Detect Doping in Sport
The field of sports genomics has identified genes and polymorphisms associated with physical
fitness phenotypes [7]. Whilst helping to understand the factors contributing to exercise performance,
knowledge of key genomic loci may also encourage unscrupulous athletes to seek performance
enhancement by delivering exogenous genetic material to the body, with the intention of increasing the
production of proteins encoded by the genetic material [90]. At present, a key challenge in detecting
such gene doping is differentiating artificial gene expression from that of normal physiological
processes [91,92]. However, it is not known if specific patterns of expression, such as those associated
with CCSs, relate to artificial gene expression, and whether such patterns could be used to differentiate
between physiological and artificial profiles. The discovery of specific CCSs related to artificial gene
expression could provide valuable blood-based screening tools in the pursuit of clean sport, though
researching this area is ethically challenging.
7.6. Diagnostic Potential of CCSs Following Exercise-Related Trauma
Many sports are associated with injuries, with many internal and external factors influencing
their occurrence [93]. Whilst many sports injuries and traumas are minor and resolve within weeks,
others incur significant short- and long-term impairment. A noteworthy trauma is concussion,
defined as a traumatically-induced transient disturbance of brain function that occurs when external
forces of different intensities provoke rapid acceleration-deceleration of the brain [94]. Concussion
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occurs most frequently in contact sports and leads to a period of ‘metabolic brain vulnerability’ [95].
The duration of this period is highly variable from one concussion to another and can also vary
between individuals [96], and secondary head trauma within this period seems particularly dangerous.
Importantly, this period persists longer than measurable symptoms and often beyond the return of
neuropsychological testing values to baseline, with many concussed patients being asymptomatic [97].
In light of these observations and the absence of structural damage from concussion, a number of
approaches to measure the alterations in cellular function associated with concussion are proposed as
diagnostic markers. Altered gene expression from sports-related concussion [98] leads us to suggest
that a CCS might be associated with the regulation of genomic loci following concussive episodes
and could discriminate between a concussed and non-concussed state. Indeed, the differentiation
of physiological states by binary readout is a key characteristic of CCSs, meaning the presence or
absence of a CCS has potential as a stable diagnostic marker for identifying molecular consequences
of concussion. Such a marker may be particularly useful when symptoms have subsided or may
never have been present at all. If combined with existing assessment protocols, detecting a molecular
genomic signature of concussive injury would benefit physicians in the management and monitoring of
athletes, allowing the temporary removal of affected athletes from competition and adding confidence
when clearing unaffected athletes to return to action.
8. Conclusions
Initial applications of CCSs in biomedical research demonstrate promising findings, highlighting
a potential new approach to investigating the epigenomic mechanisms underpinning exercise-related
phenotypes. At present, we are not aware of published studies in the fields of sport and exercise science
and medicine investigating how CCSs respond to external stimuli, or the regulatory role of CCSs in
determining biological responses and adaptations. The features of CCSs described within the present
review indicate the potential for this newly developed method to allow sport and exercise researchers
to test a range of hypotheses related to personalised sport and exercise medicine. Appropriate design
of exercise-related studies will allow researchers to address two very distinct applications of CCSs.
Exploring the responsiveness of CCSs to acute and chronic stimuli can be investigated by comparing pre-
and post-intervention states. In contrast, the regulatory role and prospect of a CCS to hold predictive
ability can be investigated by identifying individuals who respond differently to an intervention and
evaluating whether a specific pre-intervention CCS (i.e., prospective of the stimulus) is associated with
the extent or nature of the subsequent response/adaptation. Thus, chromosome conformation presents
an intriguing new potential direction for sport and exercise research.
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